http://www.allogene.com
Allogene Therapeutics, Inc. Company Intro
A clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer.
Industry
Healthcare
Allogene Therapeutics, Inc. Headquaters
210 East Grand Avenue
South San Francisco,94080
United States
Allogene Therapeutics, Inc. Share price
17 May 2023 12:45 GMT
$6.61
-0.13 (-1.93 %)
Allogene Therapeutics, Inc. Market cap
$982.97 M
WMC RANKING
2024
Allogene Therapeutics, Inc. # 129
BiotechnologyLatest Allogene Therapeutics, Inc. News
12 Feb 2024
Solid Tumor Therapeutics Market Size Worth $885.44 Billion by 2033 - Growing Government Initiatives Towards Rising ...
Solid tumor therapeutics market size from USD 222.71 Billion in 2023 to USD 885.44 Billion in 10 years. Increasing investments of pharmaceutical companies...
12 Feb 2024
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday By Benzinga
Benzinga - by Avi Kapoor, Benzinga Staff Writer. U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday.
12 Feb 2024
Is Allogene Therapeutics Inc (ALLO) a Leader in the Healthcare Sector?
Allogene Therapeutics Inc (ALLO) is near the top in its sector according to InvestorsObserver. ALLO gets an overall rating of 22.
WMC Market Score
WMC Market to Revenue Score
Allogene Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Allogene Therapeutics, Inc. | USD | $38,345 | $272,106 | $-228,756 | $9,830M | 129 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Allogene Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Allogene Therapeutics, Inc. Post vs Top 4 Industry Competitors
Allogene Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Allogene Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Allogene Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Allogene Therapeutics, Inc. | 0.42 | 12.82 | 0.03 | 0 | 0 | 0 | 4.58 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
